Ondansetron is not associated with vascular adverse events, thrombocytopenia or renal failure.
Castle
W M
WM
Cunningham
K
K
Kanarek
B B
BB
D058186:Acute Kidney Injury / Q000139:chemically induced*; D002945:Cisplatin / Q000009:adverse effects; D006801:Humans; D008787:Metoclopramide / Q000494:pharmacology; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy; D017294:Ondansetron / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced*
D017294:Ondansetron; D008787:Metoclopramide; D002945:Cisplatin